Shukra Pharmaceuticals Ltd share price logo

Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHAR

BSE: 524632

Small Cap

Pharma Sector

₹53.94

-0.03

(-0.06%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Shukra Pharmaceuticals Stock Performance

as on September 11, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹53.75
    ₹55.60
    downward going graph

    0.35%

    Downside

    3.08%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹40.06
    ₹57.44
    downward going graph

    25.73%

    Downside

    6.49%

    Upside

    downward going graph

Shukra Pharmaceuticals share price movements today

Previous Close
₹53.97
Open
₹54.05
Volume
15.77L
Upper Circuit
₹64.76
Lower Circuit
₹43.18
Day's Low - High
₹53.75 - ₹55.60
52 Week Low - High
₹40.06 - ₹57.44

Shukra Pharmaceuticals Historical Returns

1 Month Return
+ 35.46 %
3 Month Return
+ 79.98 %
1 Year Return
+ 90.4 %
3 Year Return
+ 1151.51 %
5 Year Return
+ 13056.1 %

Shukra Pharmaceuticals Fundamentals

as on September 11, 2026 at 4:01 pm IST

Market Cap

₹2,377.61 Cr

Return on Equity (ROE)

15.9

PE Ratio (TTM)

69.15

Return on capital employed (ROCE)

21.76

Industry PE ratio

51.81

Beta (LTM)

-3.36

P/B Ratio

15.17

Dividend Yield

0

PEG Ratio

121.75

Quarterly Earnings Growth YOY

1158.25

EPS (TTM)

0

Book Value

0

Shukra Pharmaceuticals Stock Valuation

as on September 11, 2026 at 4:01 pm IST

Shukra Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 26, 2025

Industry (51.81x)

September 11, 2026

Today (69.15x)

September 11, 2026

Highest (238.00x)

December 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 69.15x

Shukra Pharmaceuticals Technical Analysis

Track how Shukra Pharmaceuticals technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish12
Bullish1
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
0
Bullish
CCI (20)
401.35
Bearish
RSI (14)
44.88
Neutral
Momentum (10)
0.05
Bearish
ADI (14)
18.42
Neutral
Ultimate Oscillator (7,14,28)
25.15
Bearish

Moving Averages

Name

Value

Action

SMA (20)
53.89
Bearish
EMA (20)
53.92
Bearish
VWMA (20)
53.91
Bearish
SMA (50)
53.97
Bearish
EMA (50)
53.97
Bearish
SMA (200)
54.28
Bearish
EMA (200)
54.21
Bearish
KAMA (200)
54.13
Bearish
DEMA (200)
53.99
Bearish

Shukra Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Shukra Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Shukra Pharmaceuticals Ltd image
Shukra Pharmaceuticals Ltd
NA2,377.612611.22%0.00932
Advanced Enzyme Technologies Ltd image
Advanced Enzyme Technologies Ltd
BUY3,285.38-5.77%0.53173745
Vista Pharmaceuticals Ltd image
Vista Pharmaceuticals Ltd
NA35.39-7.88%0.00-510
Vaishali Pharma Ltd image
Vaishali Pharma Ltd
NA114.4226.53%0.00699
Dishman Carbogen Amcis Ltd image
Dishman Carbogen Amcis Ltd
NA2,622.20-4.23%0.68972,931
See all

Shukra Pharmaceuticals Stock’s Investor Sentiment and Interest

Investment in Shukra Pharmaceuticals Ltd Shares on INDmoney has grown by 73.93% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:73.93% versus previous 30 day period

Search interest for Shukra Pharmaceuticals Ltd Stock has increased by 250% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:250% versus previous 30 day period

Shukra Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
10.58
13.27
5.39
5.88
39.13
6.32
23.52
Other Income
1.01
1.47
1.11
1.71
0.82
0.95
0.54
Total Income
11.59
14.74
6.5
7.59
39.95
7.27
24.06
Expenses
6.65
5.95
4.07
6.3
12
5.62
4.38
Operating Profit
3.93
7.32
1.32
-0.42
27.13
0.7
19.14
Operating Profit Margin %
37.15%
55.16%
24.49%
-7.14%
69.33%
11.08%
81.38%
Profit Before Interest, Tax and Depreciation
4.94
8.78
2.43
1.29
27.95
1.65
19.68
Interest
0.15
0.27
0.27
0.29
0.28
0.26
0.43
Depreciation
0.7
0.94
0.79
0.81
0.84
1.01
1.08
Profit Before Tax
4.09
7.57
1.37
0.19
26.83
0.38
18.17
Tax Paid
0.93
2.18
0.35
-2.18
6.46
2.1
5.21
Profit After Tax
3.16
5.39
1.03
2.38
20.36
-1.72
12.96
Total Net profit including share of profit / Loss from associate company
3.16
5.39
1.03
2.38
20.36
-1.72
12.96
EPS
0.72
0.12
0.02
0.05
0.47
-0.04
0.3
Actual EPS
0.72
0.12
0.02
0.05
0.47
-0.04
0.3
Adjusted EPS
0.07
0.12
0.02
0.05
0.47
-0.04
0.3
Diluted EPS
0.72
0.12
0.02
0.05
0.47
-0.04
0.3

Shukra Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2025
Mar 2026
Sales
32.59
56.73
Other Income
4.21
4.58
Total Income
36.79
61.31
Expenses
19.86
27.99
Operating Profit
12.73
28.74
Operating Profit Margin %
39.06%
50.66%
Profit Before Interest, Tax and Depreciation
16.94
33.32
Interest
0.59
1.09
Depreciation
3
3.44
Profit Before Tax
13.35
28.79
Tax Paid
3.76
6.73
Profit After Tax
9.58
22.06
Total Net profit including share of profit / Loss from associate company
9.58
22.06
EPS
0.22
0.5
Actual EPS
0.22
0.5
Adjusted EPS
0.22
0.5
Diluted EPS
0.22
0.5

Shukra Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
2.72
-0.29
0.84
0.26
1.24
0.54
7.99
3.17
-5.2
7.92
Cash Flow from Investing Activities
-0.41
-0.93
-4.75
-2.45
-3.35
-1.88
-1.53
-4.43
-1.2
-1.26
Cash Flow from Financing Activities
-1.16
-
3.46
2.38
1.99
1.74
-6.67
4.94
12.4
-4.51
Net Cash Flow
1.15
-1.22
-0.46
0.18
-0.12
0.38
-0.21
3.68
6.01
2.14

Shukra Pharmaceuticals Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Aug 2026
Promoters
50.96%
50.96%
50.96%
50.96%
50.96%
50.96%
50.96%
50.96%
50.96%
50.96%
50.96%
51.15%
DII
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
Public
48.93%
48.93%
48.93%
48.93%
48.93%
48.93%
48.93%
48.93%
48.93%
48.93%
48.92%
48.73%
Total Outstanding Shares
1,09,46,986
1,09,46,986
4,37,87,944
4,37,87,944
4,37,87,944
43,78,79,440
43,78,79,440
43,78,79,440
43,78,79,440
43,78,79,440
43,78,79,440
43,96,14,440
Total Shareholders
10,963
12,974
14,989
16,321
17,844
18,231
20,337
21,441
25,649
27,173
28,384
28,384

Shukra Pharmaceuticals Corporate Actions

View detailed summary of the earnings and dividend history of Shukra Pharmaceuticals.

  • Shukra Pharmaceuticals Ltd Earnings Results

    Shukra Pharmaceuticals Ltd’s net profit jumped 1158.25% since last year same period to ₹12.96Cr in the Q1 2026-2027. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated 853.49% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Shukra Pharmaceuticals Ltd Dividends May,2026

    In the quarter ending March 2026, Shukra Pharmaceuticals Ltd has declared dividend of ₹0.01 per share on 07 May 2026 - translating a dividend yield of 0.02%.

    Read More about Dividends

Insights on Shukra Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 50.96% to 51.15% in Aug 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, SHUKRAPHAR stock has moved up by 35.5%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 48.92% to 48.73% in Aug 2026 quarter

About Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Ltd Formerly known Relish Pharmaceuticals Limited was established in March 1993 and later on the name of Company got changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on 22 September 2016. The Company is presently engaged in the business of manufacturing of pharmaceuticals Products and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics Penicillin Anti Biotics Cephalosporin Anti Biotics Macrolides Quinolones Anti Bacterial Anti Fungal Anti Malarial Anti Viral Anti Protozoal Anti Anthelmintic Sedative and Tranquilliser Anti Depressant Anti Manic Anti Emetic Anti Ulcer Beta Blockers Diuretics Analgesic Analgesic NASID Muscle Relaxants Anti Tuberculosis Vitamin Products Anti Allergics Corticosteroids Hyper and Hypoglycemic Others.The company has four manufacturing divisions namely tablets General and Beta Lactum Capsules General and Beta Lactum Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat.The company customers include leading Manufacturers like Cadila Healthcare Limited Zydus Intas Pharmaceuticals Limited Cadila Pharmaceuticals Limited Makers Laboratories Limited Agenta Pharma Limited etc.The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.In FY 201314 the Company got approval from Honble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited Transferor Company with Relish Pharmaceuticals Limited Transferee Company and Reorganization of Share Capital of Relish Pharmaceuticals Limited Transferee Company through Scheme of Arrangement vide Honble High Court of Gujarat order dated 20 Dec 2013..

Revenue: ₹23.52Cr as on June 2026 (Q1 FY27)
Net Profit: ₹12.96Cr as on June 2026 (Q1 FY27)
Listing date: 14 Aug, 2026
Chairperson Name: Dakshesh Shah
OrganisationShukra Pharmaceuticals Ltd
IndustryPharmaceuticals
CEODakshesh Shah
E-voting on sharesClick here to vote

FAQs

What is Shukra Pharmaceuticals share price today?

Shukra Pharmaceuticals share price today stands at ₹53.94 as on at the close of the market. Shukra Pharmaceuticals share today touched a day high of ₹55.6 and a low of ₹53.75.

What is the 52 week high and 52 week low range for Shukra Pharmaceuticals share?

Shukra Pharmaceuticals touched a 52 week high of ₹57.44 and a 52 week low of ₹40.06. Shukra Pharmaceuticals share price today i.e. is closed at ₹53.94, which is -6.09% down from its 52 week high and 34.65% up from its 52 week low.

What is Shukra Pharmaceuticals's market capitalisation today?

Shukra Pharmaceuticals market capitalisation is ₹2,377.61 Cr as on .

How to buy Shukra Pharmaceuticals shares?

To buy Shukra Pharmaceuticals shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SHUKRAPHAR or Shukra Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Shukra Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Shukra Pharmaceuticals trading volume today?

Shukra Pharmaceuticals trading volume is 15.77L as on . This means that 15.77L shares of Shukra Pharmaceuticals were bought and sold on the stock market during today's trading session.